← back to search

Rachel Wei

Amgen (United States) · US

Area of research

Pathology and Forensic Medicine · Genetics

Research interest

Research interests include Medicine, Internal medicine, Gastroenterology, Adverse effect, Refractory (planetary science), and Metastatic breast cancer.

h-index

—

citations

105

works

2

NIH funding

—

primary concept

—

email

✉ Find email ↗

Recent publications

OPERA-01: A randomized, open-label, phase 3 study of palazestrant (OP-1250) vs standard-of-care for ER+, HER2- advanced or metastatic breast cancer patients after endocrine therapy and CDK4/6 inhibitors.

Journal of Clinical Oncology 2024cited by 7position: middledoi

Zanubrutinib for the treatment of relapsed or refractory mantle cell lymphoma

Blood Advances 2021cited by 98position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Gavin Cull · Sir Charles Gairdner Hospital1 papers (2021–2021)Heather L. McArthur · Texas Oncology1 papers (2024–2024)Barbara Pistilli · Institut Gustave Roussy1 papers (2024–2024)Meritxell Bellet · CIBBIM-Nanomedicine1 papers (2024–2024)Joohyuk Sohn · Fudan University Shanghai Cancer Center1 papers (2024–2024)Constantine S. Tam · Alfred University1 papers (2021–2021)David Simpson · The University of Melbourne1 papers (2021–2021)Simon Rule · AstraZeneca (United Kingdom)1 papers (2021–2021)William Novotny · Addgene1 papers (2021–2021)Tycel Phillips · Michigan Cancer Research Consortium1 papers (2021–2021)Won Seog Kim · McGill University1 papers (2021–2021)Elisabeth De Kermadec · Novartis (Switzerland)1 papers (2024–2024)Lucia Del Mastro · Associazione Italiana Di Oncologia Medica1 papers (2024–2024)Judith Trotman · Repatriation General Hospital1 papers (2021–2021)Jane Meisel · Emory University1 papers (2024–2024)Stephen Opat · Monash Health1 papers (2021–2021)Javier Muñoz · Creighton University1 papers (2021–2021)Michael Wang · University of Guelph1 papers (2021–2021)Jane Huang · Los Angeles Medical Center1 papers (2021–2021)— · 1 papers (2024–2024)